Furthermore, the protein levels of RBM47 were decreased in ccRCC cancer tissues in public database (the Clinical Proteomic Tumor Analysis Consortium, CPTAC) and clinical samples with immunohistochemistry (Fig. 1e and f). This evidence concerns the gene RBM47 and neoplasm.